메뉴 건너뛰기




Volumn 117, Issue 8, 2011, Pages 1595-1601

Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer

Author keywords

breast cancer; estrogen receptor; local recurrence; locoregional recurrence; progesterone receptor

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

EID: 79953802271     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25694     Document Type: Article
Times cited : (11)

References (18)
  • 1
    • 2342552056 scopus 로고    scopus 로고
    • Prognostic molecular markers in early breast cancer
    • DOI 10.1186/bcr777
    • Esteva FJ, Hortobagyi GN., Prognostic molecular markers in early breast cancer. Breast Cancer Res. 2004; 6: 109-118. (Pubitemid 38607664)
    • (2004) Breast Cancer Research , vol.6 , Issue.3 , pp. 109-118
    • Esteva, F.J.1    Hortobagyi, G.N.2
  • 2
    • 37249004281 scopus 로고    scopus 로고
    • Predictive markers in breast cancer - The present
    • DOI 10.1111/j.1365-2559.2007.02897.x
    • Payne SJ, Bowen RL, Jones JL, Wells CA., Predictive markers in breast cancerâthe present. Histopathology. 2008; 52: 82-90. (Pubitemid 350265187)
    • (2008) Histopathology , vol.52 , Issue.1 , pp. 82-90
    • Payne, S.J.L.1    Bowen, R.L.2    Jones, J.L.3    Wells, C.A.4
  • 3
    • 18844421831 scopus 로고    scopus 로고
    • Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma
    • DOI 10.1002/cncr.21030
    • Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI., Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. 2005; 103: 2241-2251. (Pubitemid 40686567)
    • (2005) Cancer , vol.103 , Issue.11 , pp. 2241-2251
    • Grann, V.R.1    Troxel, A.B.2    Zojwalla, N.J.3    Jacobson, J.S.4    Hershman, D.5    Neugut, A.I.6
  • 4
    • 19344364880 scopus 로고    scopus 로고
    • Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687-1717.
    • (2005) Lancet. , vol.365 , pp. 1687-1717
  • 5
    • 0000719778 scopus 로고    scopus 로고
    • Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomised trials
    • Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998; 351: 1451-1467.
    • (1998) Lancet. , vol.351 , pp. 1451-1467
  • 6
    • 0032423729 scopus 로고    scopus 로고
    • Steroid hormone receptors in breast cancer management
    • DOI 10.1023/A:1006132427948
    • Osborne CK., Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat. 1998; 51: 227-238. (Pubitemid 29054556)
    • (1998) Breast Cancer Research and Treatment , vol.51 , Issue.3 , pp. 227-238
    • Osborne, C.K.1
  • 7
    • 79953778669 scopus 로고    scopus 로고
    • NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 1.2009. Fort Washington, PA: National Comprehensive Cancer Network.
    • NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 1.2009. Fort Washington, PA: National Comprehensive Cancer Network; 2009.
    • (2009)
  • 9
    • 42549116694 scopus 로고    scopus 로고
    • Current issues in ER and HER2 testing by IHC in breast cancer
    • DOI 10.1038/modpathol.2008.34, PII MODPATHOL200834
    • Gown AM., Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol. 2008; 21 (suppl 2): S8-S15. (Pubitemid 351592775)
    • (2008) Modern Pathology , vol.21 , Issue.SUPPL. 2
    • Gown, A.M.1
  • 10
    • 73349119689 scopus 로고    scopus 로고
    • High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller
    • et al.
    • Gonzalez-Angulo AM, Litton JK, Broglio KR, et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol. 2009; 27: 5700-5706.
    • (2009) J Clin Oncol. , vol.27 , pp. 5700-5706
    • Gonzalez-Angulo, A.M.1    Litton, J.K.2    Broglio, K.R.3
  • 11
    • 77955504676 scopus 로고    scopus 로고
    • Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer
    • et al.
    • Albert JM, Gonzalez-Angulo AM, Guray M, et al. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys. 2010; 77: 1296-1302.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.77 , pp. 1296-1302
    • Albert, J.M.1    Gonzalez-Angulo, A.M.2    Guray, M.3
  • 12
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P., Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 547-581.
    • (1958) J Am Stat Assoc. , vol.53 , pp. 547-581
    • Kaplan, E.L.1    Meier, P.2
  • 16
    • 0026747130 scopus 로고
    • Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group study
    • et al.
    • Ravdin PM, Green S, Dorr TM, et al. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J Clin Oncol. 1992; 10: 1284-1291.
    • (1992) J Clin Oncol. , vol.10 , pp. 1284-1291
    • Ravdin, P.M.1    Green, S.2    Dorr, T.M.3
  • 17
    • 0038688478 scopus 로고    scopus 로고
    • Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
    • DOI 10.1200/JCO.2003.09.099
    • Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM., Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in 2 large breast cancer databases. J Clin Oncol. 2003; 21: 1973-1979. (Pubitemid 46606386)
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.10 , pp. 1973-1979
    • Bardou, V.-J.1    Arpino, G.2    Elledge, R.M.3    Osborne, C.K.4    Clark, G.M.5
  • 18
    • 77954526150 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    • et al.
    • Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010; 28: 2784-2795.
    • (2010) J Clin Oncol. , vol.28 , pp. 2784-2795
    • Hammond, M.E.1    Hayes, D.F.2    Dowsett, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.